Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders-Reference-Cited by-同舟云学术

Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders

Published:2023-01-31 Issue:6 Volume:8 Page:5983-5994
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Fiorillo Bianca¹^ORCID,Roselli Rosalinda¹,Finamore Claudia¹,Biagioli Michele²,di Giorgio Cristina²,Bordoni Martina³,Conflitti Paolo⁴,Marchianò Silvia²,Bellini Rachele²,Rapacciuolo Pasquale¹,Cassiano Chiara¹,Limongelli Vittorio¹⁴^ORCID,Sepe Valentina¹^ORCID,Catalanotti Bruno¹^ORCID,Fiorucci Stefano²,Zampella Angela¹^ORCID

Affiliation:

1. Department of Pharmacy, University of Naples “Federico II”, Via D. Montesano, 49, I-80131 Naples, Italy

2. Department of Medicine and Surgery, University of Perugia, Piazza L. Severi, 1-06132 Perugia, Italy

3. Precision BioTherapeutics, Srl, Perugia 06128, Italy

4. Faculty of Biomedical Sciences, Euler Institute, Università della Svizzera italiana (USI), via G. Buffi 13, CH-6900 Lugano, Switzerland

Funder

Centro Svizzero di Calcolo Scientifico

Universit? degli Studi di Napoli Federico II

H2020 European Research Council

Ministero dell'Istruzione, dell'Universit? e della Ricerca

Publisher

American Chemical Society (ACS)